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Abstract
Background: The key management strategy for established coronary heart disease (CHD) patients is to control the
underlying risk factors. Further complications will be reduced when these risk factors are treated-to-target (TTT) as
recommended by clinical practice guidelines. These targets include blood pressure (BP) lower than 130/80 mm Hg
and LDL-cholesterol of less than 2.6 mmol/L and for those with type 2 diabetes mellitus (DM), HBA1c less than 7%.
This article aimed to explore the issues affecting this approach from both the patients’ and primary care physicians’
(PCP) perspectives.
Methods: The study involved triangulation of research methods to determine the findings. Part A: focus group
discussions to collect qualitative data from patients with CHD and from PCPs who were managing them in primary
care. Part B: A subsequent questionnaire survey to determine the extent of their awareness of treatment targets for
modifiable risk factors.
Results: CHD patients had variable awareness of the modifiable risk factors for CHD due to poor concordance between
the PCPs’ approach in managing the CHD patients and the latter’s reception of information. 46% of participants knew
their targets of BP control correctly; 11% of them were correct in stating their target for LDL-cholesterol control.
Amongst these participants with DM (n = 146), 27% of them were correct in indicating their target of diabetic control.
Conclusions: Communication and practice barriers exist which hinder the treat-to-target approach in mitigating
the risk factors for CHD patients. Incorporating this approach in routine clinical practice by PCPs has greater
potential to achieve treatment targets for patients.
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Background
Hypertension, dyslipidaemia and diabetes mellitus are
prime risk factors for coronary heart disease (CHD). Glo-
bal clinical practice guidelines recommend controlling
these risk factors as a management strategy to mitigate the
risk of recurrent CHD. Hence, physicians managing these
patients should focus on treating these modifiable risk fac-
tors to evidence-based targets. However, most CHD
patients failed to reach these targets [1,2]. In Singapore,
deaths from CHD has only declined marginally from
19.8% in 2007 to 19.2% in 2009 [3] Moreover, Ho KT et al
[4] reported that 70% of CHD patients in a cohort study of
CHD patients from the Singapore National Cardiac Regis-
try did not achieve a serum LDL-C target of < 100 mg/dL
(2.6 mmol/L). 94% of the very high risk patients did not
achieve the stringent serum LDL-C target of < 70 mg/dL
(1.8 mmol/L).
Locally, patients with CHD are often discharged to pri-
mary care from cardiologists in tertiary institutions, once
their conditions are stabilised after the acute cardiac
events. Due to the dual healthcare system in Singapore,
CHD patients can select their primary care physicians
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public polyclinics or the private general practitioner
clinics. To reduce their CHD associated mortality and
morbidity risks, more effective disease management in
primary care is urgently needed. Secondary prevention of
recurrent CHD by adopting “Treat-to-target” (TTT)
approach towards their risk factors is being advocated a
cluster of polyclinics in Singapore.
This study aimed to determine the issues associated
with this “TTT” approach in managing the health of
CHD patients in primary care in Singapore.
Methods
A mixed-method was used in this study. A qualitative
study (CAD study) which aimed to explore the manage-
ment issues of PCP and their CHD patients was first
carried out. This was followed by a cross-sectional
quantitative study (HEALTH study) of a larger sampling
of CHD patients, whose aim was to substantiate and
complement the earlier qualitative data based on the
same source population. This paper presents the results
of this triangulation method from both a qualitative
study and quantitative survey. Both studies were
approved by SingHealth Polyclinics Institution Review
Board.
Part 1: CAD (Coronary Artery Disease) study
Focus group discussions (FGD), executed between
September 2005 and March 2007, were used to gather
qualitative data from (a) patients and separately, from
(b) PCPs [5,6]. These target participants were identified
by the investigators based on a case-encounter basis at
the research sites. Snowball sampling method was also
used to recruit potential participants. The latter were
invited to take part in the FGD if they were able to
understand and communicate in English. They were
also screened for eligibility using the following criteria:
(a) The participants were adult CHD patients treated
with the following modalities: percutaneous, transluminal
coronary angioplasty (PTCA), coronary arterial bypass
grafting (CABG) or non-invasive pharmacological treat-
ment. They were diagnosed with CHD for at least one
year, based on polyclinic medical records and confirmation
based on referral documents from cardiologists.
(b) The PCPs included polyclinic doctors and general
practitioners from singleton and group practices, who
were managing CHD patients in the community.
Purposive selection of these participants from a variety
of demographic profiles was conducted to ensure multi-
variate construct of the study population in both groups.
Investigators took turns to facilitate the FGDs based
on semi-structured topic guide developed after mutual
deliberations. All FGDs were audio-taped for subsequent
transcription by independent transcribers. The
investigators carried out debrief after each FGD. Any
new concepts and ideas were noted and included in the
topic guide for discussion in the subsequent FGD. The
study was terminated after saturation of ideas as
assessed by the investigators.
The investigators used the software package NVivo7
(QSR International Pty Ltd, Australia) to code the ver-
batim transcripts and organised them into emergent
themes.
Based on findings generated by qualitative content
analysis of the CAD study, themes considered to be
important were included in the design of the question-
naire to be used in part two of the study.
Part 2: HEALTH (Heart patients’ Expectation of care,
Awareness of disease, Lifestyle modifications, Targets of
treatment and Health-seeking behaviour) study
This cross-sectional surveyw a sac o l l a b o r a t i v es t u d y
between SingHealth Polyclinics and Ngee Ann Polytech-
nic School of Nursing. The investigators deliberated and
designed the HEALTH study questionnaire based on
preliminary qualitative data from the CAD study. The
surveys were carried out by the polytechnic student
nurses in the nine SingHealth Polyclinics from June 07
to September 07. These interviewers received briefings
from the investigators to clarify implementation issues
and to standardise the execution of the survey. They
were supervised by their polytechnic tutors.
The participants satisfied the same inclusion and
exclusion criteria of the CAD study. The questionnaire
comprised thirty questions pertaining to CHD patients’
expectation of care, awareness of disease, lifestyle modi-
fications, targets of treatment and their health-seeking
behaviours. The questionnaire content was derived from
issues raised during the CAD study to ensure internal
validity. No external validation was done due to absence
o fl o c a lp r e c e d e n ts t u d ya n dt h es i m p l ed e s i g no ft h e
questions.
CHD participants were asked by the student nurses if
they were aware of their treatment targets for blood
pressure, LDL-C (LDL-cholesterol) and glycated haemo-
globin (where relevant), with “yes”, “no” and “don’t
know” answers. For affirmative answers, the participants
were expected to identify correctly the appropriate tar-
get range based on multiple choices. Blood pressure is
targeted at lower than130 mm Hg (systolic) and lower
than 80 mm Hg (diastolic), which is standardised for all
CHD patients based on the investigators’ institution
clinical practice guidelines.
Categorical variables were tabulated and analysed
using Stata-10 software (StataCorp LP, USA). All inves-
tigators deliberated the results in both segments of the
study. SingHealth Polyclinics institution review board
approved the two studies.
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The demographic profiles of 44 participants (including 3
participants on follow up by private primary care clinics
and 2 were managed at specialist clinics) in the CAD
study are shown in Table 1 and that of 303 participants,
of the HEALTH study are depicted in Table 2. The pro-
files of the 18 PCPs from 3 FGDs are shown in Figure 1.
Theme 1: Gap in communication between PCPs and CHD
patients on specific goals of treatment, with differences
in foci and expectation between the two parties during
the consultation
CHD participants were generally satisfied when their
PCPs reported that their disease control was adequate.
They did not expect to be told of their specific treat-
ment targets.
When asked if the doctors discussed the treatment
target of blood pressure (BP) control with patients,
polyclinic participant (aged 67 years, FGD3) replied:
“N o .M yd o c t o r ,t h a tIl a s ts a ws a i d :“Ok, your blood
pressure is good”, that’s all. I don’t know what is good,
what is not good.”
Similarly in FGD4, when asked about treatment target
for cholesterol, polyclinic participant A: “In e v e ra s kt h e
doctor how much. Never say good or no good.” Polyclinic
participant B in the same FGD: “They (doctors) say all
my cholesterol is good.”
On the other hand, PCPs were preoccupied with clini-
cal assessment of cardiac status to exclude any acute
myocardial event in their consultation with CHD
patients. Specifying treatment targets with their patients
was not mentioned in all three FGDs. There was lack of
discussion of mutually agreed goals of treatment
between PCPs and their CHD patients.
PCP (FGD1)
“I usually ask them whether they have any new symp-
toms, like chest pain, breathlessness on walking. If they
say, well I’m, that’s okay. So the next thing I would find
out is whether they are compliant with their medications.
If they’re a bit on the obese side, I ask them if they are
doing anything about diet control, and estimate their
understanding of their weight, and some risk factors. If
they’re smoking, check whether they would stop. If all are
okay, I would check their blood pressure. If the blood
pressure is quite under control, then I would ask them if
they are worried about anything else. Are they satisfied?
Yes, everything is fine; I would just repeat the same med-
ication. But if for example, the panel test is not done
within the last year, I would advise that they do another
one, and from the panel test, I can follow up next visit
and see whether the cholesterol, and sugar etcetera are
under control, or it’s getting out of control.”
In this study, it appeared that acute presentation of chest
pain was a more common reason of consultation with
PCPs in private clinics. In the context of potential litiga-
tion risk, their focus was to exclude potentially life-threa-
tening acute cardiac event. PCPs were aware of the
common risk factors of CHD but they did not generally
Table 1 Demographic profile of participants in CAD Study
FGD* (n) Gender Age
(years)
Race Highest educational Level attained Site of follow-up
Male Female ≤ 60 > 60 Chinese Malay Indian Others Secondary or below JC/Diploma/Tertiary Polyclinic GP/Specialist
1 (8) 6 2 5 3 7 0 1 0 6 2 8 0
2 (6) 5 1 2 4 3 1 1 1 4 2 6 0
3 (7) 6 1 4 3 4 1 2 0 7 0 6 1
4 (11) 10 1 5 6 7 0 2 2 8 3 8 3
5 (12) 10 2 7 5 7 1 3 1 10 2 11 1
Total (44) 37 7 23 21 28 3 9 4 35 9 39 5
*FGD: Focus Group Discussion (n: number of participants in the respective FGD)
Table 2 Demographic profile of 303 participants in
HEALTH Study
Age (years) No of patients (%)
41-60 79 (26.1)
61-70 87 (28.7)
71-80 137 (45.2)
Gender
Male 182 (60.1)
Female 121 (39.9)
Ethnic groups
Chinese 223 (73.6)
Malay 43 (14.2)
Indian 31 (10.2)
Others 6 (2.0)
Education
Primary/Secondary 275 (90.8)
Junior college/diploma/tertiary 28 (9.2)
Duration of coronary heart disease (years)
< 1 16 (5.3)
1-5 101 (33.3)
> 5 186 (61.4)
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factors to their patients
When asked about what took place in a consultation with
CHD patients, PCP (FGD1)
“Management of ischemic heart disease is primarily his-
tory taking (and) risk assessment. In our practice, a lot of
patients complain of chest pain. If we end up referring
all of them to cardiologist, we are not exercising enough
clinical judgement. We are liable... if the history is typi-
cal of chest pain, I will refer immediately to A and E
(Accident and Emergency). But if the history and the rest
of risk factors are not there, then I will do an ECG and
do my own assessment. But there’s still a small chance,
but your risk is low. So I always discuss options with the
patient. Sometimes the atypical chest pain may still be
angina, or acute myocardial infarct. If I find that this
patient is very demanding, I may jeopardize my license,
so I will formally refer. In one month there are so many
cases with chest pain you cannot afford to refer all of
them. For those chronic cases, you realize that they are
just musculoskeletal pain, you can just give painkiller.”
PCP (FGD1)
“In the private sector, we see two types of ischemic heart
disease patients. Those fresh cases, they’ve never been
worked up, they step into the consultation room and in
the course of the consultation we realize that they may
have underlying ischemic heart disease. The second group
is the stable angina patient. They have been worked up
somewhere else and decide to follow up in the clinic. For
the new cases, if they come in with fairly new onset of
angina symptoms, I think they deserve a more thorough
cardiologist’s review. By the time these patients come to
us, they have other risk factors to take into consideration,
like smoking, cholesterol. So looking at these risk factors,
they would have some degree of narrowing of the coronary
arteries. How severe (are the arteries affected), it is beyond
our assessment at the primary care level. In a sense, we
are still controlling symptoms. Chronic cases would be
treated like those in the polyclinic.”
Theme 2: Difficulty in remembering the numerical
treatment targets amongst CHD patients
Patient (FGD4)
“Ic a n ’t remember but I think LDL should be kept to
within 60 (mg/dl) or what, I can’t remember the exact
figure.”
CHD patients appeared to experience difficulty in
remembering the treatment targets, with some incor-
rectly perceived it to be a variable target.
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Figure 1 Profile of doctors who participated in CAD Study.
Tan and Ho Asia Pacific Family Medicine 2011, 10:12
http://www.apfmj.com/content/10/1/12
Page 4 of 6When asked about BP treatment target, Patient A
(FGD2): “120 (mmHg). More than 120... still on the high
side.” In the same FGD, Patient B indicated “130-140
(mmHg)” as the target BP control and polyclinic partici-
pant 3 (aged 55 years): “Fluctuate lah. This kind of thing
(treatment target) fluctuates.”
The lack of awareness of treatment targets is
expounded In the HEALTH study. 30% of CHD patients
were aware of the correct target BP control, 27% for
correct HBA1c target level and 11% for the appropriate
LDL-cholesterol level (Figure 2).
Theme 3: Inadequate understanding of the glycated
haemoglobin as the treatment target for CHD patients
with diabetes mellitus
In this study, 48% of the CHD patients in the HEALTH
study have type 2 diabetes mellitus. Amongst these dia-
betic CHD patients, there was confusion between serum
glucose level and glycated haemoglobin as the treatment
target. Awareness of the treatment target for diabetes
mellitus was also lacking amongst these patients.
Patient (FGD3)
“For diabetes, the level should be six and below.” When
probed by the moderator on the reference blood test,
the same patient replied: “It’s the one that they poke
(with) the needle. I can’t remember the name of the test.”
Patient (FGD2)
“What I understand (HBA1c), it is the three months’ aver-
age. With the blood (glucose) test, you can cheat: you don’t
eat, your reading will be low. But with the three months’
average, whether you eat or don’t eat, it will show. I think
it should be below ten; seven, eight, I think it’s acceptable.”
Discussion
Effective prevention of recurrent CHD encompasses a
comprehensive range of therapeutic interventions to
manage the various risk factors, from lifestyle modifi-
cations, weight management, smoking cessation to
medications [7]. This presents a challenge to the PCPs,
who face time and resource constraints in their prac-
tices and the imperatives of other immediate issues
raised by the CHD patients during the consultation.
However, PCPs have the unique advantage of mana-
ging these patients from a holistic perspective with
opportunities to recognise the various risk factors and
commence preventive interventions. This entails a
paradigm shift from merely counselling and motivating
patients to embark on healthy lifestyles to empowering
the patients to recognise their respective treatment tar-
gets. Discussion should focus on addressing the issues
pertaining to lifestyle modifications [8] and negotiation
on mutually agreed measures to achieve the treatment
targets.
Whilst patient-dependent lifestyle modifications are
important, PCPs should mitigate their patients’ modifi-
able risk factors such as blood pressure, LDL-cholesterol
and diabetic control by optimising physician-initiated
pharmaceutical interventions to reach evidence-based
treatment targets. Physician-centred intervention alone
may be inadequate. To achieve these targets, they
should communicate such goals to patients and negoti-
ate for mutual agreement during the physician-patient
consultation. The rationale and benefits behind this
treat-to-target approach should be explained to patients
in lay language, such that the latter can understand and
embrace as an essential component of their CHD
management.
45% of CHD patients in the HEALTH study were
above 70 years of age and 98% of them had, at most,
secondary education. In view of age and educational
status, educating these patients to remember their treat-
ment targets would require innovative measures. These
include provision of aide-memoires, diaries and educa-
tional literature detailing target values to patients and
their caregivers, developing enhanced health education,
outreach programmes, quiz, games or other support
group activities that focus on treatment targets. How-
ever such multi-modal interventions need further
research evaluation to ascertain their cost-effectiveness.
Only 27% of diabetic CHD patients correctly identified
the glycated haemoglobin target for their diabetic
control. Whilst it is uncertain if understanding the true
nature of the test makes any impact in their diabetic
control, simplifying the diabetic treatment target to a
single value may be easier for these patients to assimi-
late the information.
In the local setting, the private primary care clinics are
serviced by off-site commercial laboratory vendors. In
contrast, in-house laboratory service is provided within
the public polyclinics. These polyclinics are affiliated to
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their laboratory services. Laboratory reports for LDL-C
in private clinics (in mg/L) and the public polyclinics (in
mmol/L) differ in terms of units of the assay. This may
further increase the difficulty of remembering the cho-
lesterol treatment target amongst the patients. Whilst
conversion tables are available, a standardised unit of
measurement for LDL-C will facilitate the delivery of
CHD-related information to patients with cardiovascular
risk across the whole nation. Harmonisation of the
laboratory reports is a potential solution and this will be
implemented when the national electronic health record
system rolls out in the near future.
While this study employed triangulation approach
towards combining both qualitative and quantitative
data, the subjects recruited were mainly CHD patients
managed in public polyclinics and caution should be
exercised in generalising the results to all CHD patients
in Singapore. Most participants, who were recruited in
t h eq u a l i t a t i v eC A Ds t u d yd u et ot r a n s c r i p t i o nc o n -
straints, spoke English during the FGD, which constitu-
tes another limitation. The investigators did not include
the data pertaining to whether the CHD patients
achieved their treatment targets as such data are
published in the official websites of the two clusters of
polyclinics in Singapore.
Conclusion
Treat-to-target approach in managing risk factors for
CHD is hampered by a gap of communication between
PCPs and patients on treatment targets, leading to low
level of awareness of the latter. This may result in their
f a i l u r et oa p p r e c i a t et h er e l e v a n c eo fa c h i e v i n gt r e a t -
ment target in managing their chronic condition.
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